ICM
AKAM icon

Invenomic Capital Management’s Akamai AKAM Stock Holding History

Invenomic Capital Management’s Portfolio AKAM Stock Details AKAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-405,632
Closed -$46.6M – 118
2026
Q1 		$46.6M Sell
405,632
-265,937
-40% -$26.7M 2.14% 9
2025
Q4 		$58.6M Buy
671,569
+172,472
+35% +$14.2M 2.73% 4
2025
Q3 		$37.8M Buy
499,097
+71,173
+17% +$5.49M 1.83% 12
2025
Q2 		$34.1M Sell
427,924
-219,741
-34% -$17.1M 1.94% 10
2025
Q1 		$52.1M Buy
647,665
+309,576
+92% +$27.8M 2.63% 2
2024
Q4 		$32.3M Buy
338,089
+162,105
+92% +$15.9M 1.54% 12
2024
Q3 		$17.8M Buy
175,984
+126,021
+252% +$12.3M 0.98% 36
2024
Q2 		$4.5M Buy
+49,963
New +$4.83M 0.22% 107
2023
Q3 		– Sell
-201,145
Closed -$18.1M – 146
2023
Q2 		$18.1M Buy
201,145
+17,814
+10% +$1.53M 0.92% 37
2023
Q1 		$14.4M Buy
+183,331
New +$14.8M 0.81% 42

Other funds holding AKAM

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Invenomic Capital Management's AKAM Position: Q2 2026 in Review

Invenomic Capital Management sold out of Akamai (AKAM) in Q2 2026, closing a stake of 405,632 shares — an estimated $46.6M sold.

Invenomic Capital Management first reported a position in AKAM in Q1 2023 and held it in 10 quarters. The position peaked at $58.6M in Q4 2025. 801 funds tracked by Wall St. Rank hold AKAM as of Q2 2026.

  • Invenomic Capital Management reported no remaining Akamai position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 405,632 Akamai shares in Q2 2026, an estimated $46.6M.
  • Invenomic Capital Management first reported a position in Akamai in Q1 2023 and held it in 10 quarters.
  • Invenomic Capital Management's Akamai position peaked at $58.6M in Q4 2025.
  • 801 funds tracked by Wall St. Rank held Akamai as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.